You have 9 free searches left this month | for more free features.

Anti-Rheumatic

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myocardial Ischemia, Rheumatic Diseases Trial in Puerto Rico, United States (Caplan IVR)

Active, not recruiting
  • Myocardial Ischemia
  • Rheumatic Diseases
  • Caplan IVR
  • San Francisco, California
  • +4 more
Mar 15, 2022

Rheumatoid Arthritis Trial (Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD))

Not yet recruiting
  • Rheumatoid Arthritis
  • Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
  • (no location specified)
Nov 12, 2021

Rheumatoid Arthritis, Rheumatic Diseases Trial in Leiden (Abatacept, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Rheumatic Diseases
  • Leiden, Netherlands
    Leiden University Medical Center
Aug 16, 2022

Rheumatic Diseases, Mood Disorders Trial in Besançon (Blood sample)

Recruiting
  • Rheumatic Diseases
  • Mood Disorders
  • Blood sample
  • Besançon, France
    University Hospital
Apr 5, 2022

Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

Recruiting
  • Rheumatoid Arthritis
  • +3 more
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Apr 25, 2022

    COVID-19 in Rheumatic Inflammatory Diseases Under

    Active, not recruiting
    • Chronic Inflammatory Rheumatism
    • Biological samples
    • Montpellier, Occitanie, France
      Centre hopsitalier universitaire de Montpellier
    Jun 10, 2022

    Rheumatoid Arthritis Trial in Singapore (Musculoskeletal ultrasound program)

    Completed
    • Rheumatoid Arthritis
    • Musculoskeletal ultrasound program
    • Singapore, Singapore
      (unnamed)
    Oct 25, 2020

    Rheumatic Arthritis Trial in Germany (Tofacitinib, Etanercept)

    Recruiting
    • Rheumatic Arthritis
    • Berlin, Germany
    • +5 more
    Mar 1, 2022

    PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS

    Recruiting
    • Inflammatory Rheumatism
    • +5 more
      • Angers, France
      • +9 more
      May 4, 2022

      Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)

      Terminated
      • Rheumatoid Arthritis
      • Pondicherry, India
        Department of Clinical Immunology , Jawaharlal Institute of Post
      Jul 25, 2021

      Clinical Audit on Managment in Assiut University Children

      Completed
      • Rheumatic Fever
      • C reactive protein, anti streptolysin o antibody test ,erythrocyte sedimentation rate
      • Assiut, Egypt
        Egypt
      Mar 24, 2021

      Psoriatic Arthritis Trial in Worldwide (Deucravacitinib, Placebo)

      Recruiting
      • Psoriatic Arthritis
      • Jonesboro, Arkansas
      • +127 more
      Aug 12, 2022

      Active Polyarticular Juvenile Idiopathic Arthritis Trial in Worldwide (Abatacept)

      Active, not recruiting
      • Active Polyarticular Juvenile Idiopathic Arthritis
      • Abatacept
      • Birmingham, Alabama
      • +54 more
      Nov 17, 2021

      Rheumatoid Arthritis Trial in United States (SAN-300 0.5 mg/kg QW, SAN-300 1.0 mg/kg QW, SAN-300 2.0 mg/kg QOW)

      Completed
      • Rheumatoid Arthritis
      • SAN-300 0.5 mg/kg QW
      • +5 more
      • Phoenix, Arizona
      • +11 more
      Jun 18, 2021

      Rheumatoid Arthritis (RA) Trial in Brazil, China, Korea, Republic of (Upadacitinib, Placebo)

      Completed
      • Rheumatoid Arthritis (RA)
      • Curitiba, Parana, Brazil
      • +42 more
      Aug 30, 2021

      Psoriatic Arthritis Trial in Worldwide (Deucravacitinib, Placebo, Apremilast)

      Recruiting
      • Psoriatic Arthritis
      • Birmingham, Alabama
      • +136 more
      Jul 29, 2022

      Rheumatoid Arthritis Trial in Worldwide (Filgotinib, Placebo to match filgotinib, csDMARDs)

      Completed
      • Rheumatoid Arthritis
      • Huntsville, Alabama
      • +103 more
      Apr 21, 2021

      Arthritis, Psoriatic Trial in Worldwide (Placebo matching BMS-945429, BMS-945429)

      Completed
      • Arthritis, Psoriatic
      • Placebo matching BMS-945429
      • BMS-945429
      • San Diego, California
      • +48 more
      Oct 7, 2021

      Rheumatic Heart Disease in Children Trial (Rituximab added to standard of care treatment, standard of care treatment)

      Not yet recruiting
      • Rheumatic Heart Disease in Children
      • Rituximab added to standard of care treatment
      • standard of care treatment
      • (no location specified)
      Jan 3, 2023

      Rheumatoid Arthritis Trial in United States (SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway

      Active, not recruiting
      • Rheumatoid Arthritis
      • SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System
      • Aventura, Florida
      • +3 more
      Apr 22, 2021

      Rheumatoid Arthritis Trial in Clermont-Ferrand (Blood test)

      Not yet recruiting
      • Rheumatoid Arthritis
      • Blood test
      • Clermont-Ferrand, France
        CHU Clermont-Ferrand
      Sep 20, 2022

      Rheumatic Diseases Trial in Portland (Hepatitis A vaccine, Diphtheria, pertussis, and tetanus booster vaccine)

      Recruiting
      • Rheumatic Diseases
      • Hepatitis A vaccine
      • Diphtheria, pertussis, and tetanus booster vaccine
      • Portland, Oregon
        Oregon Health & Science University
      Sep 14, 2022

      Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)

      Recruiting
      • Rheumatoid Arthritis
      • +8 more
      • COVID-19 vaccine
      • Montréal, Quebec, Canada
      • +1 more
      Jan 13, 2023

      Rheumatoid Arthritis, Inflammatory Arthritis, Arthritis Trial in United States (Herpes Zoster (HZ) Vaccine, Placebo)

      Completed
      • Rheumatoid Arthritis
      • +7 more
      • Herpes Zoster (HZ) Vaccine
      • Placebo
      • Birmingham, Alabama
      • +33 more
      Oct 23, 2021

      Adverse Events in Patients Treated With Immune Check Point

      Recruiting
      • Immune-related Adverse Event
      • Antiinflammatory/DMARDs
      • Kristiansand, Norway
      • +4 more
      Sep 15, 2022